Hikma Pharmaceuticals PLC (HIK.DI)

Also known as:  Hikma
Data delayed by 15 minutes
56.71 USD 0.000.00%
As of 20 NOV 2007 09:44 GMT|Nasdaq Dubai

Hikma Stock Price & Performance Powered By Knowledge Direct

Recommendation
-
Div Yield
0.917%
P/E (Last 12 Month)
0.0
Upside
-
Target Price (Mean)
-
52Wk
0.0
0.0

Open
Data not available
Previous Close
56.71 USD
Turnover
Data not available
EPS
1.493 USD
Volume
0
Transactions
0
Market Cap
13.13B USD
IPO Date
01-Nov-2005
Analyst Recommendation
Sell
Hold
Buy
Analyst Rating
Strong Buy
Buy
Hold
Sell
Strong Sell

About Hikma Pharmaceuticals PLC

Country of Incorporation
Established In
1978
Primary Sector
Stock Listing
IDStock TypeCurrencyExchangeSymbol
HIK.DIFXOrdinaryUSDNasdaq DubaiHIK

Contact details

Primary address
Street: 13 Hanover Square
Area: Mayfair
P.O. Box: W1S 1HW
Country: United Kingdom
City: London
Region
London
More
All Press Releases
All Health Care News
All Markets News

Ownership

Revenue
Net Income
Profit Margin
Total Assets
Total Liabilities
Debt to Assets
Operating
Investing
Financing

Company information provided by Refinitiv

Refinitiv research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).

Friday Outlook: Asian stocks recover; dollar set for sparkling week

Friday Outlook: Asian stocks recover; dollar set for sparkling week

Investors juggle positive economic news with mixed corporate earnings

More

Most Viewed Stocks

Stock Screener

More